Gregory T. Fulton

Gregory T.
Fulton joined Anika Therapeutics, Inc. in 2007 as Vice President of Ophthamics and Aesthetics and became Chief Commercial Officer in April 2008.
He was Vice President-US Marketing for Genzyme Biosurgery.
Mr. Fulton began his career at Eli Lilly and Company in 1981.
He received a BS degree in Marketing Management from Virginia Polytechnic Institute and State University and an MBA from the Colgate Darden Graduate School of Business Administration at the University of Virginia.